Autologous conditioned serum (ACS) -- a biologic therapy that famous athletes swear by to treat arthritis and sports injuries -- also shows benefit for the kind of neurological pain caused by chemotherapy or diabetes.

A Conversation with Svati Shah, MD, about One DukeGEN, an initiative that uses genetics and advanced technologies to quickly translate scientific discovery into better clinical treatments.

The COVID-19 pandemic forced medical residency programs to change their approach to interviewing, switching from traditional in-person meetings to virtual conversations via computer video. &nb

A new study from researchers in the Duke University School of Medicine suggests a potential targeted therapy for otherwise untreatable forms of advanced prostate cancer.

Medical students at Duke University School of Medicine selected John Roberts, MD; Jennifer Carbrey, PhD; and Kristen Rhodin, MD, for the annual Golden Apple Awards.

Susanna Naggie, MD, MHS, has been named director of the Duke Clinical and Translational Science Institute (CTSI), effective immediately. 

The phase 1 clinical trial, which launched last month, is testing the safety of a vaccine candidate devised under the Collaborative Influenza Vaccine Innovation Centers (CIVICs) program.

Congratulations to the 375 students from the Duke University School of Medicine who graduated on Sunday, May 14, 2023, marking the successful culmination of their hard work and dedication.&nbs

Innovations in using bone marrow from donors who aren’t a perfect match and in using cord blood have made stem cell transplants for blood cancers available to more patients.

A new gift from the R.J. Samulski Innovation Foundation has endowed a professorship in the Department of Radiation Oncology.